Cardiovascular Drug Development: Protocol Design and Methodology (Fundamental and Clinical Cardiology) - Tapa dura

 
9780824719272: Cardiovascular Drug Development: Protocol Design and Methodology (Fundamental and Clinical Cardiology)
Tapa dura
ISBN 10: 0824719271 ISBN 13: 9780824719272
Editorial: CRC Press, 1998

Sinopsis

These multidisciplinary presentations provide information essential to devising effective drug protocols in cardiovascular drug development, facilitating the approval process.
Guides researchers and developers through the government drug approval process, facilitating development, minimizing costs, and harmonizing international standards employed in the creation of vital new cardiovascular therapies!
Cardiovascular Drug Development

  • explores the delicate balance of efficacy and safety that cardiovascular therapy must achieve to gain regulatory approval
  • discusses the search for surrogates and the need in some areas for natural history endpoints
  • reviews optimum strategies for protocol design in the development of drugs to treat hypertension, cardiac arrhythmias, heart failure, coronary artery disease, and hypercholesterolemia and other lipid disorders
  • compares and contrasts the varying standards of evidence for drug approval in the United States, Europe, and Asia
  • and more!
    Cardiovascular Drug Development will prove to be a valuable asset for cardiologists, pharmacologists and pharmacists, regulatory affairs specialists, and directors of research and development for pharmaceutical companies.

    • "Sinopsis" puede pertenecer a otra edición de este libro.

    Reseña del editor

    These multidisciplinary presentations provide information essential to devising effective drug protocols in cardiovascular drug development, facilitating the approval process.
    Guides researchers and developers through the government drug approval process, facilitating development, minimizing costs, and harmonizing international standards employed in the creation of vital new cardiovascular therapies!
    Cardiovascular Drug Development

  • explores the delicate balance of efficacy and safety that cardiovascular therapy must achieve to gain regulatory approval
  • discusses the search for surrogates and the need in some areas for natural history endpoints
  • reviews optimum strategies for protocol design in the development of drugs to treat hypertension, cardiac arrhythmias, heart failure, coronary artery disease, and hypercholesterolemia and other lipid disorders
  • compares and contrasts the varying standards of evidence for drug approval in the United States, Europe, and Asia
  • and more!
    Cardiovascular Drug Development will prove to be a valuable asset for cardiologists, pharmacologists and pharmacists, regulatory affairs specialists, and directors of research and development for pharmaceutical companies.

    • "Sobre este título" puede pertenecer a otra edición de este libro.

    Editorial
    CRC Press
    Año de publicación
    1998
    Idioma
    Inglés
    ISBN 10 
    0824719271
    ISBN 13 
    9780824719272
    Encuadernación
    Tapa dura
    Número de edición
    1
    Número de páginas
    248
    Editor
    Somberg John
    Contacto del fabricante
    no disponible
    Persona responsable
    no disponible